Select a relevant service

Develop study-related protocols, case report forms (CRFs) and database tools for records management.

Make clear and accurate presentations of scientific and technical data.

Run market feasibility studies, establish customer needs, improve product performance and analyze competition.

Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder (manufacturer, payer, provider, HTA agency, etc.). See also HTA Submission.

Identify, promote and prove the value of a particular drug to key stakeholders.

Design phase 1-3 studies that seek to identify if a drug is safe, effective, and more efficient than other available treatments on the market.

Analyze the lifecycles of the products and services with regard to their environmental impacts.

A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used throughout all stages of the drug development process, from Pre-investigational, to NDA.

Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics

Complex document that entails the entire clinical research strategy of a drug, describing the clinical studies that will be carried out for a pharmaceutical entity.